Silke van Koningsbruggen-Rietschel
Overview
Explore the profile of Silke van Koningsbruggen-Rietschel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rumpf C, Janssen T, Hait R, Romme K, Decker C, Peters J, et al.
Am J Respir Crit Care Med
. 2025 Feb;
PMID: 39918841
Rationale: The mucoid phenotype of is caused by adaptation. Excessive biofilm formation associated with a protective effect for mucoid was observed in isolates from respiratory samples of people with cystic...
2.
Gramegna A, Addy C, Allen L, Bakkeheim E, Brown C, Daniels T, et al.
J Cyst Fibros
. 2024 May;
23(3):375-387.
PMID: 38789317
This is the final of four papers updating standards for the care of people with CF. That this paper "Planning a longer life" was considered necessary, highlights how much CF...
3.
Sloan C, Sherrard L, Einarsson G, Dupont L, van Koningsbruggen-Rietschel S, Simmonds N, et al.
J Cyst Fibros
. 2024 Feb;
23(3):499-505.
PMID: 38360460
Background: Prescribers have an increasing range of inhaled antimicrobial formulations to choose from when prescribing both eradication and chronic suppression regimens in cystic fibrosis (CF). This study aimed to investigate...
4.
Burgel P, Southern K, Addy C, Battezzati A, Berry C, Bouchara J, et al.
J Cyst Fibros
. 2024 Jan;
23(2):187-202.
PMID: 38233247
This is the third in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on recognising...
5.
Southern K, Addy C, Bell S, Bevan A, Borawska U, Brown C, et al.
J Cyst Fibros
. 2023 Dec;
23(1):12-28.
PMID: 38129255
This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing...
6.
Jakwerth C, Weckmann M, Illi S, Charles H, Zissler U, Oelsner M, et al.
Am J Respir Crit Care Med
. 2023 Dec;
209(8):947-959.
PMID: 38064241
The strongest genetic risk factor for childhood-onset asthma, the 17q21 locus, is associated with increased viral susceptibility and disease-promoting processes. To identify biological targets underlying the escalated viral susceptibility associated...
7.
Simonis A, Kreer C, Albus A, Rox K, Yuan B, Holzmann D, et al.
Cell
. 2023 Nov;
186(23):5098-5113.e19.
PMID: 37918395
Drug-resistant Pseudomonas aeruginosa (PA) poses an emerging threat to human health with urgent need for alternative therapeutic approaches. Here, we deciphered the B cell and antibody response to the virulence-associated...
8.
Southern K, Burgel P, Castellani C, De Boeck K, Davies J, Dunlevy F, et al.
J Cyst Fibros
. 2023 Oct;
22(6):961-962.
PMID: 37798158
No abstract available.
9.
Castellani C, Simmonds N, Barben J, Addy C, Bevan A, Burgel P, et al.
J Cyst Fibros
. 2023 Sep;
22(6):963-968.
PMID: 37775442
There is considerable activity with respect to diagnosis in the field of cystic fibrosis (CF). This relates primarily to developments in newborn bloodspot screening (NBS), more extensive gene analysis and...
10.
Hagmeyer L, van Koningsbruggen-Rietschel S, Matthes S, Rietschel E, Randerath W
Clin Respir J
. 2023 Apr;
17(6):487-498.
PMID: 37054701
Inhalation therapy represents the standard of care in children, adolescents as well as in young, middle-aged and geriatric adults with asthma or chronic obstructive pulmonary disease. However, there are only...